Mindpeak has announced the European launch of PhenoScout AI, its advanced multiplex immunofluorescence (mIF) analysis solution, which it says sets a new standard with faster, reproducible and scalable insights for biomarker discovery and precision medicine.
PhenoScout AI harnesses Mindpeak’s proprietary mIF algorithms to deliver actionable insights and spatial biology data at unprecedented speed and reproducibility. By eliminating manual inefficiencies and enabling automated analysis of complex tissue samples, the platform accelerates biomarker discovery, standardises translational research and advances the future of precision diagnostics.
Developed with the support of strategic industry partners including Zeiss; PhenoScout AI integrates seamlessly with leading microscopy and imaging platforms, ensuring interoperability and streamlined adoption for research teams worldwide.
“Spatial biology is opening a new chapter in oncology and immunology research, but the scale and complexity of multiplex data have been a significant barrier,” said Felix Faber, CEO of Mindpeak. “PhenoScout AI, changes this by providing researchers with a powerful, interoperable tool that extracts meaningful results quickly, consistently, and at scale. Together, we’re enabling discoveries that can move from the lab bench to the clinic more seamlessly.”
Dr Fabian Schneider added: “As a Senior Product Manager for Multiplex Image Analysis AI at Mindpeak GmbH, I’ve witnessed firsthand how PhenoScout harnesses foundation models to unlock the full potential of multiplex immunofluorescence (mIF) analysis. Traditionally, setting up image analysis pipelines and generating bioinformatic readouts has been a major bottleneck, requiring extensive expertise and time. PhenoScout bridges this gap by providing an out-of-the-box solution that simplifies and standardises spatial biology image analysis workflows. This accelerates the path from complex image data to actionable biological insights, enabling researchers to focus on discovery rather than infrastructure.”
PhenoScout AI delivers a best-in-class workflow for high-plex tissue image analysis modality for laboratories, biopharma partners and research centres. The solution enables investigators to efficiently identify phenotypes, quantify biomarker expression and unlock spatial readouts that are essential for advancing personalised medicine.
The European launch of PhenoScout AI - at Oxford Global’s Precision Medicine: Redefining the Future of Healthcare conference – marks a significant step in Mindpeak’s strategy to support pharmaceutical companies, diagnostics developers and academic centres in advancing biomarker programmes. By combining Mindpeak’s AI expertise with Zeiss’ hardware excellence, PhenoScout AI delivers an end-to-end solution designed to meet the demands of translational and clinical research.